{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:50:42Z","timestamp":1791049842683,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":730,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/jidsymp.2013.8","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T14:32:19Z","timestamp":1386685939000},"page":"S28-S30","source":"Crossref","is-referenced-by-count":105,"title":["The Biology of IL-15: Implications for Cancer Therapy and the Treatment of Autoimmune Disorders"],"prefix":"10.1016","volume":"16","author":[{"given":"Thomas A.","family":"Waldmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jidsymp.2013.8_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2011-04-346759","article-title":"Increased serum soluble IL-15R\u03b1 levels in T-cell large granular lymphocyte leukemia","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"10.1038\/jidsymp.2013.8_bb0015","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1182\/blood-2007-09-113654","article-title":"Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1038\/jidsymp.2013.8_bb0020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(02)00429-6","article-title":"IL-15R alpha recycles and presents IL-15 in trans to neighboring cells","volume":"17","author":"Dubois","year":"2002","journal-title":"Immunity"},{"key":"10.1038\/jidsymp.2013.8_bb0025","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1182\/blood-2010-09-305425","article-title":"CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM\/TSP","volume":"117","author":"Ju","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jidsymp.2013.8_bb0030","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1182\/blood-2011-09-377804","article-title":"IL-15 administered by continuous intravenous infusion to rhesus macaques induces massive expansion of the CD8+ T effector memory population in peripheral blood","volume":"118","author":"Sneller","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jidsymp.2013.8_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/jidsymp.2013.8_bb0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2012-08-450585","article-title":"Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia","volume":"121","author":"Waldmann","year":"2013","journal-title":"Blood"},{"key":"10.1038\/jidsymp.2013.8_bb0045","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1182\/blood-2010-10-311456","article-title":"Safety (toxicity), pharmacokinetics, immunogenicity and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques","volume":"117","author":"Waldmann","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jidsymp.2013.8_bb0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10875-012-9849-y","article-title":"Tofacitinib, a Janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease","volume":"33","author":"Yokoyama","year":"2013","journal-title":"J Clin Immunol"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087002415305244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087002415305244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T04:24:46Z","timestamp":1538972686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087002415305244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1087002415305244"],"URL":"https:\/\/doi.org\/10.1038\/jidsymp.2013.8","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}